KONINKLIJKE PHILIPS NV (PHIA.AS)

NL0000009538 - Common Stock

18.85  -0.04 (-0.24%)

Fundamental Rating

3

Taking everything into account, PHIA scores 3 out of 10 in our fundamental rating. PHIA was compared to 54 industry peers in the Health Care Equipment & Supplies industry. PHIA has a bad profitability rating. Also its financial health evaluation is rather negative. PHIA is not valued too expensively and it also shows a decent growth rate.



2

1. Profitability

1.1 Basic Checks

In the past year PHIA was profitable.
PHIA had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: PHIA reported negative net income in multiple years.
Of the past 5 years PHIA 4 years had a positive operating cash flow.

1.2 Ratios

PHIA has a Return On Assets of -1.58%. This is comparable to the rest of the industry: PHIA outperforms 47.17% of its industry peers.
PHIA has a Return On Equity of -3.87%. This is comparable to the rest of the industry: PHIA outperforms 49.06% of its industry peers.
Industry RankSector Rank
ROA -1.58%
ROE -3.87%
ROIC N/A
ROA(3y)1.3%
ROA(5y)2.5%
ROE(3y)2.33%
ROE(5y)5.25%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

PHIA's Operating Margin has declined in the last couple of years.
PHIA's Gross Margin of 41.00% is on the low side compared to the rest of the industry. PHIA is outperformed by 71.70% of its industry peers.
PHIA's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for PHIA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 41%
OM growth 3Y-40.52%
OM growth 5Y-26.4%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.47%
GM growth 5Y-1.32%

3

2. Health

2.1 Basic Checks

PHIA does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for PHIA has been reduced compared to 1 year ago.
The number of shares outstanding for PHIA has been reduced compared to 5 years ago.
Compared to 1 year ago, PHIA has a worse debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of 1.52, we must say that PHIA is in the distress zone and has some risk of bankruptcy.
PHIA has a worse Altman-Z score (1.52) than 62.26% of its industry peers.
PHIA has a debt to FCF ratio of 4.76. This is a neutral value as PHIA would need 4.76 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 4.76, PHIA is in the better half of the industry, outperforming 75.47% of the companies in the same industry.
PHIA has a Debt/Equity ratio of 0.58. This is a neutral value indicating PHIA is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.58, PHIA is doing worse than 64.15% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF 4.76
Altman-Z 1.52
ROIC/WACCN/A
WACC6.24%

2.3 Liquidity

PHIA has a Current Ratio of 1.20. This is a normal value and indicates that PHIA is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of PHIA (1.20) is worse than 67.92% of its industry peers.
A Quick Ratio of 0.78 indicates that PHIA may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.78, PHIA is doing worse than 67.92% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.2
Quick Ratio 0.78

5

3. Growth

3.1 Past

PHIA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 30.53%, which is quite impressive.
Measured over the past years, PHIA shows a decrease in Earnings Per Share. The EPS has been decreasing by -2.67% on average per year.
Looking at the last year, PHIA shows a small growth in Revenue. The Revenue has grown by 1.92% in the last year.
Measured over the past years, PHIA shows a small growth in Revenue. The Revenue has been growing by 0.05% on average per year.
EPS 1Y (TTM)30.53%
EPS 3Y-15.7%
EPS 5Y-2.67%
EPS growth Q2Q0%
Revenue 1Y (TTM)1.92%
Revenue growth 3Y1.62%
Revenue growth 5Y0.05%
Revenue growth Q2Q-6.64%

3.2 Future

The Earnings Per Share is expected to grow by 17.30% on average over the next years. This is quite good.
Based on estimates for the next years, PHIA will show a small growth in Revenue. The Revenue will grow by 4.66% on average per year.
EPS Next Y8.91%
EPS Next 2Y13.09%
EPS Next 3Y12.64%
EPS Next 5Y17.3%
Revenue Next Year1.66%
Revenue Next 2Y3.34%
Revenue Next 3Y3.85%
Revenue Next 5Y4.66%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 15.20, PHIA is valued correctly.
Based on the Price/Earnings ratio, PHIA is valued cheaper than 92.45% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 24.76. PHIA is valued slightly cheaper when compared to this.
PHIA is valuated correctly with a Price/Forward Earnings ratio of 13.96.
PHIA's Price/Forward Earnings ratio is rather cheap when compared to the industry. PHIA is cheaper than 84.91% of the companies in the same industry.
PHIA is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 21.26, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 15.2
Fwd PE 13.96

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of PHIA indicates a somewhat cheap valuation: PHIA is cheaper than 62.26% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of PHIA indicates a rather cheap valuation: PHIA is cheaper than 96.23% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 10.58
EV/EBITDA 19.83

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as PHIA's earnings are expected to grow with 12.64% in the coming years.
PEG (NY)1.71
PEG (5Y)N/A
EPS Next 2Y13.09%
EPS Next 3Y12.64%

0

5. Dividend

5.1 Amount

PHIA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

KONINKLIJKE PHILIPS NV

AMS:PHIA (4/19/2024, 7:00:00 PM)

18.85

-0.04 (-0.24%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap17.09B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 15.2
Fwd PE 13.96
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)1.71
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.58%
ROE -3.87%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 41%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.62
Health
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.2
Quick Ratio 0.78
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)30.53%
EPS 3Y-15.7%
EPS 5Y
EPS growth Q2Q
EPS Next Y8.91%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)1.92%
Revenue growth 3Y1.62%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y